The Trend Is the Aussie Dollar Bulls' Friend
September Australian dollar futures (A6U25) present a buying opportunity on more price strength.
See on the daily bar chart for the September Australian dollar futures that prices are trending higher and last week hit an eight-month high. The bulls have the firm overall near-term technical advantage as 'the trend is their friend.' Price trend is the most powerful technical indicator.
Fundamentally, Australia's economy is heavily reliant on the export of raw commodities, which have seen more global demand recently. Australia and the U.S. are also on relatively good trading terms, while the U.S. and China remain at loggerheads over trade. That's Australian dollar bullish and U.S. dollar bearish.
A move in the September Aussie dollar futures prices above chart resistance at last week's high of .6550 would become a buying opportunity. The upside price objective would be .6750, or above. Technical support, for which to place a protective sell stop just below, is located at .6450.
IMPORTANT NOTE: I am not a futures broker and do not manage any trading accounts other than my own personal account. It is my goal to point out to you potential trading opportunities. However, it is up to you to: (1) decide when and if you want to initiate any trades and (2) determine the size of any trades you may initiate. Any trades I discuss are hypothetical in nature.
Here is what the Commodity Futures Trading Commission (CFTC) has said about futures trading (and I agree 100%):
Trading commodity futures and options is not for everyone. IT IS A VOLATILE, COMPLEX AND RISKY BUSINESS. Before you invest any money in futures or options contracts, you should consider your financial experience, goals and financial resources, and know how much you can afford to lose above and beyond your initial payment to a broker. You should understand commodity futures and options contracts and your obligations in entering into those contracts. You should understand your exposure to risk and other aspects of trading by thoroughly reviewing the risk disclosure documents your broker is required to give you.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
13 hours ago
- Globe and Mail
RTX's Arm Secures $300M Contract for ESSM Block II Missile Assemblies
RTX Corporation 's RTX business segment, Raytheon, recently secured a $299.7 million modification contract involving the Evolved Seasparrow Missile (ESSM). Per the terms of the deal, RTX will provide test equipment and spares, as well as exercise options for ESSM Block 2 guided missile assemblies. Details of RTX's Deal The work related to this contract will be executed in multiple locations globally, including the United States, Australia, Canada, Norway, the Netherlands and a few other nations. This contract is projected to be completed by September 2030. The award has been provided by the Naval Sea Systems Command, Washington, D.C. What's Favoring RTX? With countries worldwide enhancing their defense capabilities, spending on advanced military arms and ammunition has been rapidly increasing lately. This includes growing investments in missiles and missile systems, which are essential for modern warfare. RTX, as a prominent manufacturer of missile systems, has thus been witnessing a steady flow of orders from the Pentagon and other U.S. allies. The recent contract is an example of that. RTX's ESSM Block II is a versatile, combat-proven naval defense system with more than 330 successful live sea firings. Offering enhanced performance over Block I, it strengthens fleet protection against diverse threats. These advanced features likely drive its growing demand, reflected in the latest contract win. RTX's Growth Prospects Rising military conflicts, terrorism and border disputes have led nations to increase their focus on national security, particularly on missile defense systems in recent times, backed by the rapid development of advanced missile technologies over the last decade. This is likely to have prompted the Mordor Intelligence firm to forecast a compound annual growth rate of 5% for the global missiles and missile defense systems market during the 2025-2030 time period. Such strong growth projections indicate solid opportunities for RTX, which has a handful of combat-proven missiles in its product portfolio, like the TOW missile, Guidance Enhanced Missile, Advanced Medium Range Air-to-Air Missile, Tomahawk, Standard Missile 2 and a few more, in addition to the ESSM. Opportunities for Other Defense Stocks Other defense companies that are likely to enjoy the perks of the expanding missiles and missile system market have been discussed below: Northrop Grumman NOC: Northrop Grumman provides high-speed, long-range strike weapons like the AARGM-ER, which is a supersonic, air-launched tactical missile system. It also builds advanced missile defense technology, ranging from command systems to directed energy weapons, advanced munitions and powerful sensors. The company's long-term (three to five years) earnings growth rate is 3.3%. The Zacks Consensus Estimate for NOC's 2025 sales indicates year-over-year growth of 2.8%. The Boeing Company BA: It manufactures various missile defense systems, including the Ground-based Midcourse Defense, Aegis Ballistic Missile Defense and Avenger. Boeing-built missile defense systems have been protecting its customers for nearly 25 years against threats ranging from intercontinental ballistic missiles to hostile aircraft. The company has a long-term earnings growth rate of 18.1%. The Zacks Consensus Estimate for BA's 2025 sales indicates year-over-year growth of 25.6%. Lockheed Martin LMT: Lockheed Martin's missile defense program includes the Patriot Advanced Capability-3 and Terminal High-Altitude Area Defense air and missile defense programs. It also manufactures the Multiple Launch Rocket System, the Joint Air-to-Surface Standoff Missile and Javelin tactical missiles. The company has a long-term earnings growth rate of 10.5%. The Zacks Consensus Estimate for LMT's 2025 sales indicates year-over-year growth of 4.7%. RTX Stock's Price Movement Shares of RTX have gained 25.1% in the past six months compared with the industry 's 15.5% growth. RTX's Zacks Rank RTX currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks Names #1 Semiconductor Stock It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA): Free Stock Analysis Report Lockheed Martin Corporation (LMT): Free Stock Analysis Report Northrop Grumman Corporation (NOC): Free Stock Analysis Report RTX Corporation (RTX): Free Stock Analysis Report This article originally published on Zacks Investment Research (
Globe and Mail
13 hours ago
- Globe and Mail
Intelligent Bio Solutions (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS's first shift to in-house, on-site drug testing for pre-employment, random, and for-cause purposes. The fingerprint-based system delivers non-invasive results in under ten minutes, enabling rapid safety decisions without disrupting field operations. INBS continues to expand its reach into safety-critical industries, with its scalable, sweat-based drug testing now in use by over 450 organizations across 24 countries. To view the full article, visit About Intelligent Bio Solutions Inc. Intelligent Bio Solutions Inc. is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company's current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners. About BioMedWire BioMedWire ('BMW') is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness. BMW is where breaking news, insightful content and actionable information converge. To receive SMS alerts from BioMedWire, 'Biotech' to 888-902-4192 (U.S. Mobile Phones Only) For more information, please visit Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: BioMedWire Austin, Texas 512.354.7000 Office Editor@ BioMedWire is powered by IBN
CTV News
2 days ago
- CTV News
Price of gold could drop to US$2,500: commodities expert
Sorry, we're having trouble with this video. Please try again later. [5006/404] Gold's rally may be over, according to a commodities expert who predicts prices to drop substantially late next year to well under US$3,000 an ounce. Max Layton, global commodities head at CITI Research, predicts gold will trade at about $2,500 to $2,700 in the second half of next year, down about $900 or so less than where it is today. 'Our call is very much a 2026 bearish gold call,' Layton told BNN Bloomberg in a Thursday interview. 'Near term, we have it averaging around $3,200 in the third quarter and $3,000 in the fourth quarter.' Gold reached $3,382.40 per ounce Thursday and is up by more than 70 per cent over the past two years. Layton said CITI had been bullish on gold for the last couple of years as investors flocked to the precious metal. He said people are buying gold to hedge against a downside risks to their household wealth over fears of slowing economic growth and global uncertainty. 'The move from $2,600 to $3,300 this year has been all about investors buying bars and coins, particularly bars because they're hedging against a downside in U.S. and global growth, as well as a downside in equities related to that downside in U.S. and global growth, which has come about because of the combination of still extremely high interest rates in the U.S. by historical standards, and the tariffs.' He however expects a drop in prices due to weakening investment demand, anticipated U.S. interest rate cuts and improved economic prospects. 'We're getting close to this One Big Beautiful Bill Act passing Congress,' said Layton. 'We think that is going to mark a shift in sentiment towards U.S. growth and basically a slight reduction, or even a moderate reduction, or even possibly by the end of next year, heading into the mid terms with lower interest rates as well.' The bill has a section citing 'remedies against unfair foreign taxes.' It is expected to hit Canadians and international investors with a higher tax on dividends they received from U.S.-based investments, placing more money in American coffers to evidentially lead to growth in the U.S.' This bill, the passing of it being net stimulatory for the U.S. economy, is going to reduce fears about growth and lead to a bit more positivity and a little less investment buying of gold,' said Layton. 'With that, you basically unwind the primary driver of the last $700 move in the old price higher from $2,600 to $3,300.' While CITI paints a bleak picture for gold prices, major financial institutions such as Goldman Sachs project prices to rise to $3,700 by late 2025 and $4,000 by mid-2006 thanks to robust central bank buying. Bank of America as well predicts prices to rise to $4,000 within 2026.
